In a patent abstract, thymosin beta‑4 and the other listed proteins were described as binding lead in cell-free binding, with a high-affinity region of dissociation constant about 10-9 M; the abstract does not say which protein this value belongs to.
In plain wordsIn lab tests, thymosin beta‑4 and other listed proteins were described as binding lead tightly.
- Peptide
- Thymosin beta-4 (human)
- Outcome
- Not applicableLead binding affinity
- Study
n: not reported in source
Lead-binding proteins- Outcome group
- Receptor activity and mechanism · Pharmacology
- Studied dose
- Dose not stated
Source sentences
Thymosin beta-4 (TB4), Thymosin beta-9 (TB9), and acyl-CoA binding protein (ACBP) are two proteins that possess the ability to bind lead in human tissue. These two proteins have a high affinity lead-binding region with a dissociation constant (Kd) of about 10-9 M that allows for a strong interaction…